Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant modified vaccinia virus Ankara (MVA) equine encephalitis virus vaccine

Recombinant modified vaccinia virus Ankara (MVA) equine encephalitis virus vaccine

US Patent 10881725 · Granted Jan 5, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and compositions for inducing protective immunity against filovirus infe2024
Poxvirus vectors encoding HIV antigens, and methods of use thereof2023
Compositions and methods for enhancing the stability of transgenes in poxviruses2023
Recombinant modified vaccinia virus ankara (MVA) equine encephalitis virus vacci2023
Recombinant modified vaccinia virus ankara (MVA) equine encephalitis virus vacci2023
Multivalent recombinant modified vaccinia virus ankara (MVA) vector encoding fil2022
Poxvirus vectors encoding HIV antigens, and methods of use thereof2022
Stable recombinant MVA vectors comprising modified RSV genes with reduced intram2022
Methods and compositions for inducing protective immunity against filovirus infe2021
Recombinant modified vaccinia virus Ankara (MVA) foot and mouth disease virus (F2021
Recombinant modified vaccinia virus Ankara (MVA) foot and mouth disease virus (F2021
Compositions and methods for enhancing the stability of transgenes in poxviruses2021